References
- Pearson T.C. Primary thrombocythaemia: diagnosis and management. British Journal of Haematology 1991; 78: 145–148
- Lofvenberg E., Nordenson I., Wahlin A. Cytogenetic abnormalities and leukemic transformation in hydroxyurea-treated patients with Philadelphia chromosome negative chronic myeloproliferative disease. Cancer Genet Cytogenet 1990; 49: 57–67
- Tefferi A., Elliott M.A., Solberg L.A., Silverstein M.N. New drugs in essential thrombocythemia and polycythemia vera. Blood Reviews 1997; 11: 1–7
- Sessarego M., Defferrari R., Dejana A.M., Rebuttato A.M., Fugazza G., Salvidio E., Ajmar F. Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study. Cancer Genet Cytogenet. 1989; 43: 57–65
- Shibata K., Shimamoto Y., Suga K., Sano M., Matzuzaki M., Yamaguchi M. Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation. A brief review of the literature. Acta Haematol 1994; 91: 84–88
- Sedlacek S.M., Curtis J.L., Weintraub J., Levin J. Essential thrombocythemia and leukemic transformation. Medicine 1986; 65: 353–364
- Barbui T., Finazzi G., Dupuy E., Kiladjian J.-J., Briere J. Treatment strategies in essential thrombocytopenia. Leukemia and Lymphoma 1996; 22(Supp 1)149–160
- Frei-Lahr D., Barton J., Hoffman R., Burkett L., Prchal J. Blastic transformation of essential thrombocythemia: Dual expression of myelomonoblastic/megakaryoblastic phenotypes. Blood 1984; 63: 866–872
- Berkahn L.C., Nelson J., Ockleford P.A., Browett P.J. Transformation of essential thrombocythaemia to T cell acute lymphoblastic leukaemia. Leukemia Lymphoma 1996; 20(3-4)347–9
- Murphy P.T., Sivakumaran M., van Rhee F., Watmore A.E., Mitchell V.E. Acute lymphoblastic transformation of essential thrombocythaemia. British Journal of Haematology 1995; 89: 921–22
- Seeker-Walker L.M., Mehta A., Bain B. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study. British Journal of Haematology 1995; 91: 490–501
- Cuneo A., Ferrant A., Michaux J.L., Boogaerts M., Demuynck H., Van Orshoven A., Criel A., et al. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: Correlation with clinicobiologic findings. Blood 1995; 85: 3688–3694
- Venditti A., Del Poeta G., Stasi R., Masi M., Bruno A., Buccisano F., Cox C., Coppetelli U., Aronica G., Simone M.D., Papa G., Tribalto M., Amadori S. Minimally differentiated acute myeloid leukaemia (AML M0): Cytochemical, immunophenotypic and cytogenetic analysis of 19 cases. British Journal of Haematology 1994; 88: 784–793
- Arthur D.C., Berger R., Golomb H.M., Swansbury G.J., Reeves B.R., Alimena G., Van den Berghe H., , from the Sixth Workshop on Chromosomes in Leukemia, et al. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet 1989; 40: 203
- Pedersen-Bjergaard J., Philip P., Olesen Larsen S., Jensen G., Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990; 76: 1083
- Pedersen-Bjergaard J., Rowley J.D. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780